PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Cancer and Genomic Science, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.\', \'Institute of Microbiology and Infection, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.\', \'Clinical Immunology Service, Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.\', \'University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.\', \'Public Health England, Birmingham, United Kingdom.\', \'Institute of Applied Health Research, College of Medical and Dental Science, University of Birmingham, Birmingham, United Kingdom.\', \'NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pbio.3001216
?:doi
?:hasPublicationType
?:journal
  • PLoS biology
is ?:pmid of
?:pmid
?:pmid
  • 33914730
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.941
?:rankingScore_hIndex
  • 214
is ?:relation_isRelatedTo_publication of
?:title
  • Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33914730>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33914730>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all